Braskem (NYSE:BAK – Get Free Report) is anticipated to release its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Braskem to post earnings of ($0.16) per share for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, November 11, 2025 at 7:00 AM ET.
Braskem (NYSE:BAK – Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.70) by $0.56. The company had revenue of $3.38 billion for the quarter, compared to analysts’ expectations of $18.76 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Braskem Stock Performance
BAK opened at $2.42 on Wednesday. The stock has a market capitalization of $962.63 million, a price-to-earnings ratio of -0.95 and a beta of 1.76. The company has a fifty day moving average of $2.88 and a 200 day moving average of $3.26. Braskem has a fifty-two week low of $2.32 and a fifty-two week high of $6.34.
Institutional Investors Weigh In On Braskem
Analyst Ratings Changes
Several research firms recently weighed in on BAK. Santander cut shares of Braskem from a “neutral” rating to an “underperform” rating in a research note on Thursday, October 16th. UBS Group cut shares of Braskem from a “buy” rating to a “neutral” rating and cut their target price for the company from $5.10 to $3.80 in a research note on Friday, September 26th. JPMorgan Chase & Co. cut their target price on shares of Braskem from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 27th. Weiss Ratings reissued a “sell (e+)” rating on shares of Braskem in a research note on Wednesday, October 8th. Finally, Citigroup cut shares of Braskem from a “buy” rating to a “hold” rating in a research note on Friday, October 10th. Five analysts have rated the stock with a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Braskem presently has an average rating of “Reduce” and a consensus price target of $4.40.
Check Out Our Latest Report on BAK
Braskem Company Profile
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Read More
- Five stocks we like better than Braskem
- 3 Monster Growth Stocks to Buy Now
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- What Makes a Stock a Good Dividend Stock?
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.
